FDA.reportPublic FDA data

Mavenclad 10 MG Oral Tablet

RxCUI
2122641
RxNorm name
Mavenclad 10 MG Oral Tablet
Display name
Mavenclad 10 MG Oral Tablet
Full name
Mavenclad 10 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:10

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MavencladCLADRIBINEEMD Serono, Inc.9c75e30a-a410-40f1-b653-04d532bd91442026-05-27Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2122641

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
9c75e30a-a410-40f1-b653-04d532bd9144Mavenclad 10 MG Oral Tablet [PSN] · cladribine 10 MG Oral Tablet [Mavenclad] [SBD] · Mavenclad 10 MG Oral Tablet [SY]310These highlights do not include all the information needed to use MAVENCLAD safely and effectively. See full prescribing information for MAVENCLAD. MAVENCLAD ® (cladribine) tablets, for oral use Initial U.S. Approval: 199320260527